Crispr Therapeutics shares owned by ExodusPoint Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by ExodusPoint Capital Management
from 13F filings
Historical chart of ExodusPoint Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by ExodusPoint Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $3.1M | 91k | 34.03 |
| 2024-12-31 | $1.9M | 48k | 39.36 |
| 2024-03-31 | $1.1M | 17k | 68.16 |
| 2023-09-30 | $1.6M | 34k | 45.38 |
| 2023-06-30 | $2.1M | 37k | 56.15 |
| 2023-03-31 | $2.4M | 53k | 45.23 |
| 2022-12-31 | $1.0M | 25k | 40.64 |
| 2022-09-30 | $1.1M | 17k | 65.33 |
| 2021-12-31 | $1.2M | 16k | 75.76 |
| 2021-09-30 | $1.0M | 9.2k | 111.94 |
| 2021-03-31 | $306k | 2.5k | 121.72 |
| 2020-12-31 | $894k | 5.8k | 153.03 |
| 2020-03-31 | $265k | 6.2k | 42.45 |
More positions owned by ExodusPoint Capital Management
View all positions for ExodusPoint Capital Management